Selvaskandan, Haresh
Cheung, Chee Kay
Muto, Masahiro
Barratt, Jonathan http://orcid.org/0000-0002-9063-7229
Article History
Received: 17 September 2018
Accepted: 17 January 2019
First Online: 13 February 2019
Compliance with ethical standards
:
: Haresh Selvaskandan, Chee Kay Cheung, Masahiro Muto have declared that no conflict of interest exists. Jonathan Barratt: Consultancies: Omeros, EMD Serono, Calliditas, Novartis, Aduro Biotech, Retrophin.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: This article does not contain any studies with human participants.